logo
[breadcrumb_custom]

Tag: Arcutis Biotherapeutics Inc. (NASDAQ:ARQT)

PNC Stock
Stock

Arcutis Biotherapeutics Inc (ARQT) Stock: Uncovering 52-Week Market Trends

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Arcutis Biotherapeutics Inc’s current trading price is -33.77% away from its 52-week high, while its distance from the 52-week low is 479.55%. The stock’s price range for this period has been between $1.76 and $15.40 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.16 million for the day, a number notably lower than the average daily volume of 4.67 million over the last three months. Arcutis Biotherapeutics Inc experienced a rather shaky

News

Arcutis Biotherapeutics Inc (ARQT) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Arcutis Biotherapeutics Inc’s current trading price is -18.64% away from its 52-week high, while its distance from the 52-week low is 611.93%. The stock’s price range during this period has varied between $1.76 and $15.40. The company, active in the Healthcare sector, saw a trading volume of around 4.91 million for the day, considerably higher average daily volume of 4.73 million observed over the last three months. Arcutis Biotherapeutics Inc’s stock has had a calm

VIPS stock
Finance

ARQT’s Market Whiplash: 199.38% YTD Rise, 2.00% Rise in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 199.38% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 48.09%. Over the past 30 days, the price of ARQT has fallen by 2.00%. And in the last five days, it has fallen by -12.57%. Arcutis Biotherapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $15.40 on 04/13/23, while

ZM Stock
Stock

ARQT’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 210.84%. However, over the past six months, we’ve seen a weaker performance of 35.31%. The price of ARQT fallen by 76.14% over the last 30 days. And in the last five days, it has fallen by -8.31%. Arcutis Biotherapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock

Stock

Arcutis Biotherapeutics Inc (ARQT Stock: A Sea of Opportunity

Arcutis Biotherapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $17.57 on 03/02/23, while the lowest price for the same period was registered at $1.76 on 12/01/23. 52-week price history of ARQT Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Arcutis Biotherapeutics Inc’s current trading price is -33.00% away from its 52-week high, while its distance from the 52-week low is 568.75%. The stock’s price range during this period has spanned from $1.76 to $17.57. In the Healthcare sector, the

Stock

Arcutis Biotherapeutics Inc (ARQT) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Arcutis Biotherapeutics Inc’s current trading price is -37.55% away from its 52-week high, while its distance from the 52-week low is 523.30%. The stock’s price range for this time frame has been between $1.76 and $17.57. The trading volume of the company’s shares in the Healthcare reached around 4.84 million for the day, which was evidently lower than the average daily volume of 5.88 million over the last three months. The market performance of Arcutis Biotherapeutics Inc has been